The Lancet

6 days ago | thelancet.com | David Collingridge

According to Gert De Meerleer (University Hospitals Leuven, Belgium) and colleagues, adding elective para-aortic radiotherapy to whole pelvic radiotherapy along with androgen deprivation therapy yields excellent oncological outcomes.

1 week ago | thelancet.com | Graham Cooke |Viet Nam |Barnaby Flower |Leanne McCabe

Introduction The development of direct-acting antivirals for hepatitis C virus (HCV) infection has transformed individual treatment and underpins ambitious WHO targets for global elimination of viral hepatitis as a public health threat by 2030.1 Of three WHO-recommended pan-genotypic first-line treatment options, two are preferred by lower-income and lower-middle-income countries and are available from generic manufacturers: sofosbuvir–daclatasvir and sofosbuvir–velpatasvir.2 No randomised...

1 week ago | thelancet.com | Antoine Kimmoun |Connor O'Brien |Vanessa Blumer

aLorraine University, Nancy Teaching Hospital, Intensive care unit, INSERM U1116, Nancy, France bDivision of Cardiology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA cInova Schar Heart and Vascular, Inova Fairfax Medical Campus, Falls Church, VA, USA dCenter for Molecular Cardiology, University of Zürich, Schlieren, Switzerland eNational Disease Registration and Analysis Service, NHS, London, UK fDepartment of Cardiovascular Sciences, University of...

2 weeks ago | thelancet.com | Eva Gamper |Madeleine King |Jim Shaw |Outcomes Research

aDepartment of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital of Psychiatry II, Medial University of Innsbruck, 6020 Innsbruck, Austria bSchool of Psychology, University of Sydney, Camperdown, NSW, Australia cGlobal Health Economics and Outcomes Research, Bristol Myers Squibb, Lawrenceville, NJ, USA dDepartment of Health Economy, Norwegian Medicines Agency, Oslo, Norway eCenter for Health Technology Assessment and Center for Pharmacology and Drug Research and...

2 weeks ago | thelancet.com | Paul Adepoju

When we think about embassies, cancer care rarely comes to mind. Diplomatic missions are traditionally associated with fostering political alliances, issuing visas, or negotiating trade deals. Yet, across Africa, embassies have been quietly stepping into the realm of public health, initiating and supporting projects aimed at combating cancer. Although these efforts have made important contributions, they often fall short of addressing the systemic challenges that perpetuate poor cancer outcomes.